FBXO3 and breast cancer: Importantly, clinical validation of human breast cancer samples reveals a significant correlation between high expression of TβRI and FBXO3 with low expression of p63 and that breast cancer patients with high TβRI/FBXO3 or low p63 exhibit poor RFS.